According to the charges, Catenacci served as one of the lead physicians and primary field investigators on a clinical trial by a California-based biotechnology company, identified only as Company A. Through this position, Catenacci allegedly received confidential information about the company and its clinical trial results.
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.